All News

Patients with head and neck cancer treated with dysphagia-optimized intensity-modulated radiotherapy had improved swallow function compared with those treated with standard intensity-modulated radiotherapy.

In conjunction with Cancer Champions, CURE® recently hosted the “Educated Patient® Webinar: An Overview of Diet and Exercise in Cancer Care."

One of the most common side effects of cancer treatment must be the chills, feeling cold all the time.

Many patients with skin cancer who were treated with immune checkpoint inhibition experienced long-term side effects, although some resolved over time, research showed.

I was devastated when I had to stop working due to my cancer diagnosis. However, I eventually found a new line of work that I'm grateful for.

Tecentriq, compared with chemotherapy, improved survival while maintaining quality-of-life in patients with non-small cell lung cancer considered ineligible for platinum-based chemotherapy.

I’ve heard of many stories of friendships dwindling after someone has been diagnosed with cancer. One thing about it is that I can relate.

An ongoing phase 1 trial is analyzing the use of a novel cancer vaccine plus the immunotherapy agent, Keytruda, for patients with triple-negative breast cancer.

When my daughter was going through cancer, I realized that connecting with one her peers going through a similar experience was incredibly helpful.

Enjoying things right in front of me.

We took a look back at the most noteworthy and compelling myeloprolifearative neoplasm stories from 2023.

Researchers conducting this trial will compare zipalertinib plus chemotherapy with chemotherapy alone in patients with previously untreated, locally advanced or metastatic non-small cell lung cancer with the EGFR exon 20 insertion mutation.

Patients with non-small cell lung cancer who recently received surgery are more susceptible to wildfire smoke exposure, worsening their overall survival rate.

Here’s a new term for me: Response shift.

As wide receiver John Metchie returns to the field after cancer experience, and coach Brent Venables announces wife’s cancer diagnosis, this is what’s happening in the oncology space this week.

Exercise was shown to reduce chemotherapy-induced peripheral neuropathy in ovarian cancer survivors, according to findings from a recent study.

In patients with cancer, clonal hematopoiesis was associated with cardiac toxicity and in increased risk of death due to heart conditions.

High-level results from a phase 3 trial demonstrated that treatment with batiraxcept did not improve progression-free survival in patients with platinum-resistant ovarian cancer.

No one talks about the “rabbit hole” that patients with cancer experience, even as time passes.

Momelotinib led to symptom, spleen and anemia benefits for patients with previously treated myelofibrosis, according to updated study findings.

A majority of women with a history of colorectal cancer experience long-term gastrointestinal symptoms, which may be associated with psychological distress, according to recent research.

Patients with inherited cancer genes who are undergoing fertility preservation before treatment may be able to learn if their embryos have the mutation as well.

The Food and Drug Administration has approved the combination of Lonsurf and Avastin for patients with metastatic colorectal cancer previously treated with chemotherapies, an anti-VEGF therapy and, if RAS wild-type, an anti-EGFR therapy.

I spent most of the past decade obsessed with self-preservation. After being diagnosed with osteosarcoma, a rare and aggressive bone cancer, this was necessary for my survival.

Findings from the phase 3 ATLAS and ENVISION trials reveal a non-surgical way to possibly benefit patients with low-grade, intermediate- risk non-muscle invasive bladder cancer.

Patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy reported higher quality of life and were less likely to experience vomiting when receiving fosaprepitant every week as opposed to every three weeks.

Researchers found a difference in outcomes between head and neck cancers with high and low expression of NF-kB, which may one day lead to more personalized treatments for the disease.